sulfasalazine has been researched along with Weight Loss in 3 studies
Sulfasalazine: A drug that is used in the management of inflammatory bowel diseases. Its activity is generally considered to lie in its metabolic breakdown product, 5-aminosalicylic acid (see MESALAMINE) released in the colon. (From Martindale, The Extra Pharmacopoeia, 30th ed, p907)
sulfasalazine : An azobenzene consisting of diphenyldiazene having a carboxy substituent at the 4-position, a hydroxy substituent at the 3-position and a 2-pyridylaminosulphonyl substituent at the 4'-position.
Weight Loss: Decrease in existing BODY WEIGHT.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Sulfasalazine and FTY720 treatment did not prevent body weight loss or reduce clinical scores of diarrhea or intestinal gross pathology, when compared with vehicle treatment." | 3.77 | Pharmacologic evaluation of sulfasalazine, FTY720, and anti-IL-12/23p40 in a TNBS-induced Crohn's disease model. ( Benson, EL; Heuvelman, DM; Masferrer, JL; Radi, ZA, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Radi, ZA | 1 |
| Heuvelman, DM | 1 |
| Masferrer, JL | 1 |
| Benson, EL | 1 |
| Adebayo, D | 1 |
| Popat, R | 1 |
| Thjodleifsson, B | 1 |
| Bjarnason, I | 1 |
| Kim, YS | 1 |
| Son, M | 1 |
| Ko, JI | 1 |
| Cho, H | 1 |
| Yoo, M | 1 |
| Kim, WB | 1 |
| Song, IS | 1 |
| Kim, CY | 1 |
3 other studies available for sulfasalazine and Weight Loss
| Article | Year |
|---|---|
Pharmacologic evaluation of sulfasalazine, FTY720, and anti-IL-12/23p40 in a TNBS-induced Crohn's disease model.
Topics: Animals; Antibodies, Monoclonal; Crohn Disease; Diarrhea; Disease Models, Animal; Female; Fingolimod | 2011 |
Granulomatous ileitis in a patient with ankylosing spondylitis.
Topics: Adult; Back Pain; Biopsy; Crohn Disease; Diagnosis, Differential; Gastrointestinal Agents; Humans; I | 2007 |
Effect of DA-6034, a derivative of flavonoid, on experimental animal models of inflammatory bowel disease.
Topics: Acetic Acid; Animals; Animals, Genetically Modified; Anti-Inflammatory Agents; Anti-Inflammatory Age | 1999 |